Short-acting β2-agonists and exacerbations in children with asthma in England: SABINA Junior
Background Prescription of three or more short-acting β2-agonist (SABA) canisters per year in adult and adolescent asthma populations is associated with a risk of severe exacerbations; however, evidence in children aged <12 years is limited. Methods This study analysed data on children and adoles...
Main Authors: | Ann Morgan, Ekaterina Maslova, Constantinos Kallis, Ian Sinha, Graham Roberts, Trung N. Tran, Ralf J.P. van der Valk, Jennifer K. Quint |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2023-04-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/9/2/00571-2022.full |
Similar Items
-
Healthcare costs associated with short-acting β2-agonists in asthma: observational UK SABINA study
by: Darush Attar-Zadeh, et al.
Published: (2023-09-01) -
Impact of COPD and asthma on in-hospital mortality and management of patients with heart failure in England and Wales: an observational analysis
by: Claudia Gulea, et al.
Published: (2022-06-01) -
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
by: Stephen G. Noorduyn, et al.
Published: (2022-09-01) -
Prevalence of Poorly Controlled Asthma and Factors Associated with Specialist Referral in Those with Poorly Controlled Asthma in a Paediatric Asthma Population
by: Kallis C, et al.
Published: (2023-10-01) -
Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III
by: Arzu Yorgancıoğlu, et al.
Published: (2022-06-01)